Kaiyan Yang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
-
- Circular RNAs in diseases 4
- Ubiquitin and proteasome pathways 3
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 3
- Co-authors
- Xiaorong Li (9 shared papers)Gui Hu (6 shared papers)Wei Wu (1 shared paper)Daojin Chen (2 shared papers)Hongxian Wang (1 shared paper)Haihua Gu (5 shared papers)Changwei Lin (6 shared papers)Fei Long (4 shared papers)
- Journals
- Cancers (2 papers)Molecular Cancer (1 paper)Communications Physics (1 paper)Oncogene (1 paper)Pregnancy Hypertension (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Kaiyan Yang
39 papers receiving 804 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 272
- Oncology 170
- Molecular Biology 390
- Pulmonary and Respiratory Medicine 105
- Pathology and Forensic Medicine 51
Countries citing papers authored by Kaiyan Yang
This map shows the geographic impact of Kaiyan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiyan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiyan Yang more than expected).
Fields of papers citing papers by Kaiyan Yang
This network shows the impact of papers produced by Kaiyan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiyan Yang. The network helps show where Kaiyan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kaiyan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 107 | |
| 2 | 2022 | 107 | |
| 3 | 2020 | 61 | |
| 4 | 2022 | 55 | |
| 5 | 2017 | 52 | |
| 6 | 2020 | 38 | |
| 7 | Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade. | 2020 | 34 |
| 8 | 2007 | 33 | |
| 9 | 2014 | 29 | |
| 10 | 2020 | 25 | |
| 11 | 2021 | 23 | |
| 12 | 2009 | 23 | |
| 13 | 2014 | 18 | |
| 14 | 2004 | 16 | |
| 15 | 2016 | 16 | |
| 16 | 2011 | 16 | |
| 17 | 2007 | 15 | |
| 18 | 2019 | 15 | |
| 19 | [Expression of microRNA-21 in invasive ductal carcinoma of the breast and its association with phosphatase and tensin homolog deleted from chromosome expression and clinicopathologic features]. | 2008 | 15 |
| 20 | 2022 | 14 |
About Kaiyan Yang
Kaiyan Yang is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Pathology and Forensic Medicine, having authored 41 papers that have together received 822 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers), Ubiquitin and proteasome pathways (3 papers), Cancer-related molecular mechanisms research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Cancer Research (272 citations), Oncology (170 citations), Molecular Biology (390 citations), Pulmonary and Respiratory Medicine (105 citations) and Pathology and Forensic Medicine (51 citations). Kaiyan Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiaorong Li, Gui Hu, Wei Wu, Daojin Chen, Hongxian Wang, Haihua Gu, Changwei Lin, Fei Long, Hongzhi Li and Zhixing Lu. Their work appears in journals such as Cancers, Molecular Cancer, Communications Physics, Oncogene and Pregnancy Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.